Ensuiko Sugar Refining Co.,Ltd.

The Ensuiko Sugar Refining Co.,Ltd. group is focused primarily on its sugar and bio businesses and comprises the company, 2 subsidiaries and 4 affiliated companies. In addition to manufacturing and selling sugar products, it manufactures and sells bio products, including lactosucrose oligosaccharide (oligosaccharide) and cyclodextrin, which it supplies to the market under brands including the Pearl Ace mark. For the fiscal year ended March 2026, consolidated net sales were ¥32,982 million, operating income was ¥3,047 million, ordinary income was ¥3,339 million and net income attributable to owners of the parent was ¥2,765 million. All increased from the previous consolidated fiscal year and reached record highs. As its medium-term targets for the fiscal year ending March 2031, the company has set net sales of ¥37,500 million, ordinary income of ¥3,300 million, net income of ¥2,300 million and ROE of at least 9.0%. Over the longer term, it has formulated NEXT 2030. In October 2025, it entered into an alliance agreement with Fuji Nihon Corporation. Its medium-term strategy is to secure stable earnings from the sugar business, diversify the earnings base of the bio business, acquire new customers by strengthening e-commerce sales, and develop new products and materials through collaboration with external partners.